# FDA Inspection 1262223 - ABBE Laboratories, Inc. - February 27, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/abbe-laboratories-inc/b637f300-b6c8-45bb-a971-c41e9c34aa07
Source feed: FDA_Inspections

> FDA Inspection 1262223 for ABBE Laboratories, Inc. on February 27, 2025. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262223
- Company Name: ABBE Laboratories, Inc.
- Inspection Date: 2025-02-27
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1063137 - 2018-08-09](https://www.globalkeysolutions.net/records/fda_inspections/abbe-laboratories-inc/71cc9e38-243d-492f-9fba-4e6a2c0853e5)
- [FDA Inspection 892592 - 2014-07-24](https://www.globalkeysolutions.net/records/fda_inspections/abbe-laboratories-inc/c56366bd-4c98-418c-ad9d-9b79cf2519d0)
- [FDA Inspection 827113 - 2013-04-12](https://www.globalkeysolutions.net/records/fda_inspections/abbe-laboratories-inc/f14d5469-5b51-4fc5-85a4-26232b83ca86)
- [FDA Inspection 783112 - 2012-05-23](https://www.globalkeysolutions.net/records/fda_inspections/abbe-laboratories-inc/e36c12b3-11a1-489f-803c-e8f03aaeadf2)
- [FDA Inspection 724721 - 2011-05-05](https://www.globalkeysolutions.net/records/fda_inspections/abbe-laboratories-inc/63d0a3e0-9185-4ecb-a61a-9b2cfb8d79da)

Company: https://www.globalkeysolutions.net/companies/abbe-laboratories-inc/81e46d34-6d12-480e-aa23-f547353a0386

Office: https://www.globalkeysolutions.net/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d